Stephen O. Mathew

920 total citations
27 papers, 680 citations indexed

About

Stephen O. Mathew is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Stephen O. Mathew has authored 27 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 5 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Stephen O. Mathew's work include Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (10 papers) and Immunotherapy and Immune Responses (6 papers). Stephen O. Mathew is often cited by papers focused on Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (10 papers) and Immunotherapy and Immune Responses (6 papers). Stephen O. Mathew collaborates with scholars based in United States, India and Singapore. Stephen O. Mathew's co-authors include Porunelloor A. Mathew, Jongrok Kim, Jamboor K. Vishwanatha, Pankaj Chaudhary, Pappanaicken R. Kumaresan, Jae‐Kyung Lee, Rahul Patel, Philip Gendall, Riyaz Basha and Taylor Gilliland and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Stephen O. Mathew

25 papers receiving 668 citations

Peers

Countries citing papers authored by Stephen O. Mathew

Since Specialization

Citations

This map shows the geographic impact of Stephen O. Mathew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen O. Mathew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen O. Mathew more than expected).

Fields of papers citing papers by Stephen O. Mathew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen O. Mathew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen O. Mathew. The network helps show where Stephen O. Mathew may publish in the future.

Co-authorship network of co-authors of Stephen O. Mathew

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen O. Mathew. A scholar is included among the top collaborators of Stephen O. Mathew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen O. Mathew. Stephen O. Mathew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Racial/Ethnic Disparities and Immunotherapeutic Advances in the Treatment of Hepatocellular Carcinoma 2024 ·Cancers ·(unknown), Stephen O. Mathew	4
2	Differential Expression of LLT1, SLAM Receptors CS1 and 2B4 and NCR Receptors NKp46 and NKp30 in Pediatric Acute Lymphoblastic Leukemia (ALL) 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), Subhash Aryal, W. Paul Bowman, Porunelloor A. Mathew, Stephen O. Mathew	3
3	Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal 2023 ·Pharmaceuticals ·Suneel Kumar, Stephen O. Mathew, (unknown), (unknown), Chakrabhavi Dhananjaya Mohan, Gautam Sethi, Kwang Seok Ahn, (unknown), Sardul Singh Sandhu, Anupam Bishayee	41
4	Blocking PCNA interaction with NKp44 enhances primary natural killer cell-mediated lysis of triple-negative breast cancer cells. 2023 ·PubMed ·(unknown), Stephen O. Mathew, Pankaj Chaudhary, (unknown), (unknown), Jamboor K. Vishwanatha, Porunelloor A. Mathew	7
5	Natural Killer Cell-Mediated Immunotherapy for Leukemia 2022 ·Cancers ·(unknown), Joel Mathews, Taylor Gilliland, Stephen O. Mathew	31
6	NK Cell Isolation and Cytotoxicity by Radioactive Chromium Release Assay and DELFIA-EuTDA Cytotoxicity Assay 2022 ·Methods in molecular biology ·(unknown), Stephen O. Mathew	7
7	The Many Faces of Innate Immunity in SARS-CoV-2 Infection 2021 ·Vaccines ·(unknown), (unknown), In-Woo Park, Harlan P. Jones, Stephen O. Mathew	10
8	Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer 2020 ·Cancers ·(unknown), Porunelloor A. Mathew, Stephen O. Mathew	50
9	Impact of the Microbiome on the Immune System 2019 ·Critical Reviews in Immunology ·(unknown), (unknown), Krishna Patel, Umesh T. Sankpal, Stephen O. Mathew, Riyaz Basha	49
10	Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction 2016 ·Oncotarget ·Stephen O. Mathew, Pankaj Chaudhary, (unknown), Jamboor K. Vishwanatha, Porunelloor A. Mathew	49
11	CS1 (SLAMF7) inhibits production of proinflammatory cytokines by activated monocytes 2013 ·Inflammation Research ·Jongrok Kim, (unknown), Stephen O. Mathew, Porunelloor A. Mathew	42
12	YY1 and a unique DNA repeat element regulates the transcription of mouse CS1 (CD319, SLAMF7) gene 2013 ·Molecular Immunology ·(unknown), Stephen O. Mathew, Irina Akopova, Ignacy Gryczyński, Porunelloor A. Mathew	11
13	Novel Interaction between Proliferating Cell Nuclear Antigen and HLA I on the Surface of Tumor Cells Inhibits NK Cell Function through NKp44 2013 ·PLoS ONE ·(unknown), Stephen O. Mathew, Porunelloor A. Mathew	54
14	2B4+ CD8+ T cells play an inhibitory role against constrained HIV epitopes 2011 ·Biochemical and Biophysical Research Communications ·Kim Aldy, (unknown), Porunelloor A. Mathew, Stephen O. Mathew	17
15	Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosus 2010 ·Clinical & Experimental Immunology ·Jongrok Kim, Stephen O. Mathew, Rahul Patel, (unknown), Porunelloor A. Mathew	57
16	Functional role of human NK cell receptor 2B4 (CD244) isoforms 2009 ·European Journal of Immunology ·Stephen O. Mathew, (unknown), Jongrok Kim, (unknown), Porunelloor A. Mathew	28
17	LLT1‐mediated Activation of IFN‐γ Production in Human Natural Killer Cells Involves ERK Signalling Pathway 2009 ·Scandinavian Journal of Immunology ·(unknown), Stephen O. Mathew, Porunelloor A. Mathew	20
18	CS1 (CRACC, CD319) Induces Proliferation and Autocrine Cytokine Expression on Human B Lymphocytes 2007 ·The Journal of Immunology ·Jae‐Kyung Lee, Stephen O. Mathew, (unknown), Pappanaicken R. Kumaresan, Porunelloor A. Mathew	64
19	Human natural killer cell receptor 2B4 (CD244) down-regulates its own expression by reduced promoter activity at an Ets element 2007 ·Biochemical and Biophysical Research Communications ·Stephen O. Mathew, (unknown), Jongrok Kim, Porunelloor A. Mathew	13
20	Mutational Analysis of the Human 2B4 (CD244)/CD48 Interaction: Lys68 and Glu70 in the V Domain of 2B4 Are Critical for CD48 Binding and Functional Activation of NK Cells 2005 ·The Journal of Immunology ·Stephen O. Mathew, Pappanaicken R. Kumaresan, Jae‐Kyung Lee, Van Huynh, Porunelloor A. Mathew	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact